首页> 外文期刊>Journal of Microbiology and Infectious Diseases >Abstract - Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India
【24h】

Abstract - Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India

机译:摘要-印度孟买一家三级医院的对碳青霉烯类耐药的肠杆菌科的流行

获取原文
           

摘要

The emergence of Carbapenem Resistant Enterobacteriaceae (CRE) in recent times has become a serious threat to public health due to the high mortality, potential dissemination rates and limited treatment options associated with these organisms. Thus, the present study was conducted in our tertiary care hospital in Mumbai, to retrospectively analyze the prevalence of CRE in the hospital. Methods The study was carried out in the microbiology department of the tertiary care hospital over a period of 12 months. The samples tested were clinical samples from hospitalized and Out-Patient Department (OPD) patients sent to the department for microbiological testing. CRE isolates were identified using the Vitek 2- Compact system (BioMérieux, France). Results A CRE prevalence rate of 12.26% was obtained from the study, from which the majority of the isolates were detected in urine samples (46%). Although most of the CRE isolates were detected in patient samples from the wards (42%) and the ICU (26%), a significant number of isolates was also detected from the OPD patients (19%). Conclusion Thus, the study shows a significant rate of carbapenem resistance among Enterobacteriaceae isolated from hospitalized and OPD patients. This emphasizes the urgent need for CRE control at the hospital and community level, and to rationalize the use of antibiotics. J Microbiol Infect Dis 2013;3(4) 87-90 Key words Carbapenem Resistant Enterobacteriaceae, Antimicrobial Stewardship Volume 03, Number 04 (2013)
机译:由于与这些生物体相关的高死亡率,潜在的传播率和有限的治疗选择,近来出现的耐碳青霉烯肠杆菌科(CRE)已成为对公共卫生的严重威胁。因此,本研究是在我们位于孟买的三级医院进行的,以回顾性分析该医院的CRE患病率。方法这项研究在三级医院的微生物科进行了为期12个月的研究。测试的样品是住院患者和门诊患者(OPD)的临床样品,这些患者已被送往该部门进行微生物检测。使用Vitek 2- Compact系统(法国BioMérieux)鉴定出CRE分离物。结果从该研究中获得的CRE患病率为12.26%,其中尿液样品中检出的大多数分离株(46%)。尽管从病房(42%)和ICU(26%)的患者样本中检出了大多数CRE分离株,但也从OPD患者中检出了大量的分离株(19%)。结论因此,该研究表明,从住院患者和OPD患者中分离出的肠杆菌科细菌对碳青霉烯的耐药率较高。这强调了在医院和社区一级迫切需要控制CRE并合理使用抗生素的迫切需要。 J微生物感染杂志2013; 3(4)87-90关键词耐碳青霉烯类肠杆菌科,抗菌管理第03卷,第04期(2013)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号